Frequently Asked Questions
The market is segmented based on , By Active Ingredients (Naloxegol, Lubiprostone, Methylnaltrexone Bromide, Docusate Sodium, and Others), Treatment (Over The Counter Medicines, Prescription, and Natural Remedies), Mode of Administration (Oral, Parenteral, and Others), End-Users (Hospitals, Homecare, Speciality Centres, and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy) – Industry Trends and Forecast to 2031.
.
The Global Opioid Induced Constipation Drugs Market size was valued at USD 2.69 USD Billion in 2023.
The Global Opioid Induced Constipation Drugs Market is projected to grow at a CAGR of 6.7% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.
